Quick answers
- Is CVE-2026-105706 exploited in the wild?
- No. Junglewise Threat Intelligence has no report of CVE-2026-105706 being exploited in the wild.
- How severe is CVE-2026-105706?
- Medium severity, with a CVSS score of 4.3, published 6 October 2026.
- Which products and versions are affected?
- SourceCodester Drug Recommendation System 1.0.
- Is there a fix for CVE-2026-105706?
- No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
- How is CVE-2026-105706 attacked?
- It is attacked over the network, in a web application.
- Am I affected by CVE-2026-105706?
- Check whether you run SourceCodester Drug Recommendation System at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.
Technical details
The application lacks Cross-Site Request Forgery (CSRF) token validation across multiple endpoints. An attacker can craft a malicious request from an external site that, when visited by an authenticated user, will perform unwanted state-changing actions within the application. The vulnerability affects an unknown function and requires the victim to be authenticated and visit a malicious link.
Affected products
- SourceCodester Drug Recommendation System 1.0
Timeline
- 2026-10-06: disclosed